Ingredion Insider Buys Shares Amid Analyst Attention

SVP David Eric Seip acquired 17 shares of Ingredion on June 15.

Key Points

  • David Eric Seip, SVP at Ingredion, purchased 17 shares at $101.50 each on June 15, 2026.
  • Ingredion trades at $101.51 with a market cap of $6.4 billion and a P/E ratio of 9.77.
  • Analysts maintain a hold consensus with a mean price target of $122.83.

David Eric Seip, Senior Vice President of Global Operations and Chief Supply Chain Officer at Ingredion Incorporated, bought 17 shares of the company on June 15, 2026. The shares were purchased at an average price of $101.50, totaling about $1,725.50. This transaction was not part of a pre-planned trading program.

Insider Buying and Selling at Ingredion Incorporated

Seip's recent purchase is part of a series of insider transactions at Ingredion. On the same day, Michael Leonard, another senior executive, also acquired 34 shares at $101.51 each. Earlier in May, both Seip and Leonard purchased additional shares at a slightly lower price of $101.44. These actions reflect ongoing insider interest in the company's stock.

Other Institutional Activity in Ingredion

Several institutional investors have also been active in Ingredion's stock. BlackRock, Inc. increased its holdings by 228,122 shares, bringing its total to 6,350,063 shares valued at approximately $715.4 million. Dimensional Fund Advisors LP added 175,600 shares, ending with a total of 3,115,136 shares worth about $351 million. First Trust Advisors LP made a significant move, boosting its position by 1,059,324 shares to a total of 3,054,149 shares, valued around $344.1 million.

Ingredion Stock Snapshot

Ingredion's stock, listed on the NYSE under the ticker INGR, is trading around $101.51. The company has a market capitalization of approximately $6.4 billion. It boasts a P/E ratio of 9.77 and a forward P/E of 8.75, indicating relatively low valuation compared to earnings. Ingredion's beta of 0.595 suggests lower volatility compared to the broader market. The stock's 52-week range is between $97.12 and $140.47.

Recent Earnings

Ingredion reported revenue of about $7.2 billion, though it experienced a slight decline of 1.2% in revenue growth. The company maintains a net margin of 9.36% and a return on equity of 16.19%. Investors can look forward to the next earnings report on August 4, 2026.

Dividend

Ingredion offers a dividend rate of $3.28 per share, yielding 3.23% annually. The dividend payout ratio stands at 31.35%, indicating a sustainable distribution to shareholders.

Analysts Set New Price Targets

Analysts have been actively adjusting their price targets for Ingredion. On May 6, 2026, Barclays maintained its hold rating with a target price of $120. Oppenheimer, on April 22, reiterated a buy rating with a target of $126. UBS also maintained its hold rating, setting a target of $122 on April 9. The consensus among analysts is a hold, with a mean target price of $122.83 based on six opinions.

About Ingredion

Ingredion Incorporated is a global company in the consumer defensive sector, specializing in packaged foods. Headquartered in Westchester, Illinois, and led by CEO James P. Zallie, the company employs around 11,000 people. Ingredion produces and sells sweeteners, starches, nutrition ingredients, and biomaterial solutions, catering to various industries worldwide. Its products are used in foods, beverages, pharmaceuticals, and industrial applications.

Bottom Line

Insider buying by senior executives at Ingredion highlights confidence in the company's prospects. The stock's current valuation, alongside institutional interest, makes it a point of interest for investors. With a mixed analyst outlook, Ingredion's performance in upcoming quarters will be closely watched. Remember, insider transactions and 13F filings reflect past actions and may not indicate current or future positions.

See Also

This instant news alert was generated by automated narrative technology and financial data from EarningsIQ and public regulatory filings. It is for informational purposes only and is not financial advice.